# US 2024/0201188 A1 · A 3-laser 13-color b cell monitoring panel and reagent kit for analyzing b cell subsets in anti-cd20 treated autoimmune patients

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0201188 A1
- Document ID: US20240201188A1
- Status: Published application
- Kind: A1
- Application number: 18/491,742
- Filed: 2023-10-20
- Published: 2024-06-20
- Earliest claimed: 2022-10-20
- Assignees: Cytek Biociences, Inc.
- Applicants: Cytek Biociences, Inc.
- Inventors: Heather Miller; Kevin Tran; Mark Edinger; Jingyi Chen; Jun Deng
- Web page: https://patentgrep.com/patent/US20240201188A1

## CPC

- G01N 33/57505: of the blood, e.g. leukaemia
- G01N 15/1429: Signal processing
- G01N 15/1459: {the analysis being performed on a sample stream}
- G01N 15/1468: {with spatial resolution of the texture or inner structure of the particle}
- G01N 33/56972: {White blood cells}
- G01N 2015/1006: {for cytology}
- G01N 2015/1402: {Data analysis by thresholding or gating operations performed on the acquired signals or stored data}
- G01N 2015/1472: {with colour}
- G01N 2015/1477: {Multiparameters}
- G01N 2333/705: Assays involving receptors, cell surface antigens or cell surface determinants
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

In one embodiment, a method of building an optimized color flow high parameter reagent 13-color panel for B cell monitoring for analyzing B cell subsets in anti-CD20 treated autoimmune patients using a full spectrum flow cytometer is disclosed. In another embodiment, a reagent kit for B cell monitoring for analyzing B cell subsets in anti-CD20 treated autoimmune patients is disclosed for use with a full spectrum flow cytometer.

## Claims

### Claim 1

A method of building a B cell monitoring panel for analyzing subsets in anti-CD20 treated autoimmune patients using a full spectrum flow cytometer, the method comprising:
selecting thirteen (13) cell markers for biological cells of interest from the table below;
selecting thirteen (13) clones related to the thirteen (13) cell markers from the table below;
identifying thirteen (13) fluorochromes to be used in the flow cytometry panel from the table below;
Fluorochromes
Marker
Clone
cFluor B515
IgM
CH2
cFluor B532
CD4
SK3
cFluor B548
CD15
HI98
cFluor BYG575
CD38
HB7
cFluor BYG610
CD27
O323
cFluor BYG667
CD14
MEM-15
cFluor BYG710
IgD
IgD26
cFluor BYG781
CD19
SJ25C1
cFluorR659
CD3
SK7
cFluor R668
IgG
4A11
cFluor R685
CD8
SK1
cFluor R720
CD20
2H7
cFluor R780
CD45
2D1
conjugating the thirteen (13) clones with the thirteen (13) fluorochromes;
calibrating the lasers and detectors in the flow cytometer;
staining the biological cells of interest with the antibody conjugated fluorochromes, comprising the thirteen (13) fluorochromes and thirteen (20) clones specific to the thirteen (13) cell markers, to create a multicolor single tube sample;
analyzing the multicolor sample through the full spectrum flow cytometer;
receiving data from the detectors of the full spectrum flow cytometer; and
processing the received data using a computer processor to form the 13-color flow cytometry panel.

### Claim 2 (depends on 1)

The method of claim 1, wherein pairing the thirteen (13) fluorochromes with the thirteen (13) selected cell markers comprises;
assigning the dimmest fluorochromes to the highest expressing antigens;
assigning tertiary markers to bright fluorochromes; and
avoiding placing highly expressed antigens adjacent to co-expressed antigens with lower expression for fluorochromes with a same primary excitation laser or similar emission wavelengths.

### Claim 3 (depends on 1)

The method of claim 1, wherein the full spectrum flow cytometer is a 3-laser flow cytometer.

### Claim 4 (depends on 1)

The method of claim 1, wherein the biological cells comprise peripheral blood cells.

### Claim 5 (depends on 1)

The method of claim 1, wherein the biological cells are collected in EDTA, Cyto-Chex BCT, or heparin tubes.

### Claim 6

A reagent kit for a full spectrum flow cytometer for B cell monitoring for analyzing subsets in anti-CD20, the reagent kit comprising:
a sample test tube having a reagent composition with the following combination of fluorochromes and clones specific to the listed cell markers:
Fluorochromes
Marker
Clone
cFluor B515
IgM
CH2
cFluor B532
CD4
SK3
cFluor B548
CD15
HI98
cFluor BYG575
CD38
HB7
cFluor BYG610
CD27
O323
cFluor BYG667
CD14
MEM-15
cFluor BYG710
IgD
IgD26
cFluor BYG781
CD19
SJ25C1
cFluorR659
CD3
SK7
cFluor R668
IgG
4A11
cFluor R685
CD8
SK1
cFluor R720
CD20
2H7
cFluor R780
CD45
2D1

### Claim 7

A reagent kit for a full spectrum flow cytometer for B cell monitoring for analyzing subsets in anti-CD20, the reagent kit comprising:
a plurality of test tubes containing one or more of combination, in the table immediately following, of fluorochromes and clones specific to the cell markers:
Fluorochromes
Marker
Clone
cFluor B515
IgM
CH2
cFluor B532
CD4
SK3
cFluor B548
CD15
HI98
cFluor BYG575
CD38
HB7
cFluor BYG610
CD27
O323
cFluor BYG667
CD14
MEM-15
cFluor BYG710
IgD
IgD26
cFluor BYG781
CD19
SJ25C1
cFluorR659
CD3
SK7
cFluor R668
IgG
4A11
cFluor R685
CD8
SK1
cFluor R720
CD20
2H7
cFluor R780
CD45
2D1

### Claim 8

(canceled)
